Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-21 Sale(A) |
2024-06-10 10:34 am |
ROCKET PHARMACEUTICALS INC. | RCKT | Makker Gotham Director |
274,000 | $28.43 | $7,790,943 | 987,412 (Indirect) |
View |
| 2024-05-16 Sale |
2024-05-20 4:36 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
1,079 | $23.35 | $25,195 | 53,327 (Direct) |
View |
| 2024-05-16 Sale |
2024-05-20 4:33 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
9,790 | $23.35 | $228,597 | 1,317,757 (Indirect Direct) |
View |
| 2024-05-16 Sale |
2024-05-20 4:29 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel |
1,048 | $23.35 | $24,471 | 128,419 (Direct) |
View |
| 2024-05-16 Sale |
2024-05-20 4:26 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
4,046 | $23.35 | $94,474 | 665,473 (Indirect Direct) |
View |
| 2024-04-22 Sale |
2024-04-24 4:06 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
833 | $22.87 | $19,051 | 54,406 (Direct) |
View |
| 2024-04-12 Sale |
2024-04-16 5:45 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | SOUTHWELL DAVID P Director |
80,000 | $24.32 | $1,945,785 | 144,408 (Direct) |
View |
| 2024-04-08 Sale |
2024-04-10 8:39 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | White Mark Andrew See Remarks |
12,532 | $24.64 | $308,763 | 75,226 (Direct) |
View |
| 2024-03-21 Sale |
2024-03-25 8:58 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Makker Gotham Director |
274,000 | $28.43 | $7,790,943 | 365,912 (Indirect) |
View |
| 2024-03-21 Sale |
2024-03-25 8:54 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
2,490 | $28.1 | $69,979 | 91,451 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-04 6:54 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
10,000 | $29.84 | $298,450 | 21,517 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-04 6:48 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel |
4,100 | $29.33 | $120,257 | 18,680 (Direct) |
View |
| 2024-02-16 Sale |
2024-02-21 8:54 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel |
3,576 | $29.84 | $106,701 | 71,871 (Direct) |
View |
| 2024-02-16 Sale |
2024-02-21 8:54 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
7,132 | $29.84 | $212,805 | 477,086 (Indirect Direct) |
View |
| 2024-02-16 Sale |
2024-02-21 8:54 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
3,238 | $29.84 | $96,615 | 46,062 (Direct) |
View |
| 2024-02-16 Sale |
2024-02-21 8:54 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
20,272 | $29.84 | $604,876 | 1,223,913 (Indirect Direct) |
View |
| 2024-01-22 Sale |
2024-01-23 4:22 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
638 | $27.2 | $17,356 | 10,159 (Direct) |
View |
| 2023-11-15 Sale |
2023-11-16 7:24 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Makker Gotham Director |
20,000 | $22.53 | $450,646 | 1,296,497 (Indirect) |
View |
| 2023-10-20 Sale |
2023-10-25 09:38 am |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
564 | $17.06 | $9,623 | 8,760 (Direct) |
View |
| 2023-02-17 Sale(A) |
2023-10-20 6:37 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
1,076 | $19.06 | $20,509 | 18,842 (Direct) |
View |
| 2023-09-28 Sale |
2023-10-02 9:02 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Makker Gotham Director |
14,989 | $21.07 | $315,744 | 1,316,497 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-13 Option Award |
2024-06-20 4:10 pm |
N/A 2034-06-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Makker Gotham Director |
23,944 | $0 | 26,604 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-20 4:10 pm |
N/A 2034-06-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Makker Gotham Director |
2,660 | $15.04 | 26,604 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-20 4:10 pm |
N/A 2034-06-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | GRANADILLO PEDRO P Director |
23,944 | $0 | 28,599 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-20 4:10 pm |
N/A 2034-06-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | GRANADILLO PEDRO P Director |
4,655 | $15.04 | 28,599 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-20 4:10 pm |
N/A 2034-06-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | BOESS CARSTEN Director |
23,944 | $0 | 23,944 (Direct) |
View |
| 2024-05-02 Gift |
2024-05-20 4:39 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | SOUTHWELL DAVID P Director |
172,840 | $0 | 114,784 (Direct) |
View |
| 2022-02-14 Other |
2024-05-20 4:33 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
91,725 | $0 | 1,317,757 (Direct) |
View |
| 2024-05-14 Exercise |
2024-05-20 4:33 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
17,662 | $0 | 1,317,757 (Direct) |
View |
| 2022-08-12 Other |
2024-05-20 4:29 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel |
45,710 | $0 | 128,419 (Direct) |
View |
| 2024-05-14 Exercise |
2024-05-20 4:29 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel |
2,420 | $0 | 128,419 (Direct) |
View |
| 2022-02-14 Other |
2024-05-20 4:26 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
103,194 | $0 | 665,473 (Direct) |
View |
| 2024-05-14 Exercise |
2024-05-20 4:26 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
15,076 | $0 | 665,473 (Direct) |
View |
| 2024-04-12 Exercise |
2024-04-16 5:45 pm |
N/A 2024-08-28 |
ROCKET PHARMACEUTICALS INC. | RCKT | SOUTHWELL DAVID P Director |
99,624 | $4.342 | 144,408 (Direct) |
View |
Ownership |
2024-04-03 6:07 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
0 | $0 | 717,192 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 6:02 pm |
N/A 2034-04-01 |
ROCKET PHARMACEUTICALS INC. | RCKT | Ondrey Aaron Chief Financial Officer |
116,118 | $0 | 116,118 (Direct) |
View |
| 2022-02-14 Other |
2024-03-25 8:54 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
36,212 | $0 | 91,451 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-04 6:54 pm |
N/A 2028-01-28 |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
10,000 | $12.55 | 21,517 (Direct) |
View |
| 2024-02-16 Option Award |
2024-02-21 8:54 pm |
N/A 2034-02-16 |
ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel |
65,735 | $0 | 71,871 (Direct) |
View |
| 2024-02-16 Option Award |
2024-02-21 8:54 pm |
N/A 2034-02-16 |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
131,471 | $0 | 477,086 (Direct) |
View |
| 2024-02-16 Option Award |
2024-02-21 8:54 pm |
N/A 2034-02-16 |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
32,867 | $0 | 46,062 (Direct) |
View |
| 2024-02-16 Option Award |
2024-02-21 8:54 pm |
N/A 2034-02-16 |
ROCKET PHARMACEUTICALS INC. | RCKT | White Mark Andrew Chief Medical Officer |
43,823 | $0 | 120,485 (Direct) |
View |
| 2024-02-16 Option Award |
2024-02-21 8:54 pm |
N/A 2034-02-16 |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
262,913 | $0 | 1,223,913 (Direct) |
View |
| 2024-02-14 Exercise |
2024-02-16 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
93,656 | $0 | 1,090,659 (Direct) |
View |
| 2024-02-14 Exercise |
2024-02-16 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
52,378 | $0 | 412,975 (Direct) |
View |
| 2024-02-14 Exercise |
2024-02-16 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel |
9,712 | $0 | 29,079 (Direct) |
View |
| 2024-02-14 Exercise |
2024-02-16 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
12,548 | $0 | 29,495 (Direct) |
View |
| 2024-01-18 Exercise |
2024-01-22 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
1,586 | $0 | 18,729 (Direct) |
View |
| 2023-12-07 Option Award |
2023-12-12 8:51 pm |
N/A 2033-12-07 |
ROCKET PHARMACEUTICALS INC. | RCKT | Woods Keith Director |
32,482 | $0 | 32,482 (Direct) |
View |
| 2023-11-14 Exercise |
2023-11-16 7:17 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
3,989 | $0 | 347,656 (Direct) |
View |
| 2023-11-14 Exercise |
2023-11-16 7:09 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
7,979 | $0 | 978,969 (Direct) |
View |
| 2023-11-14 Exercise |
2023-11-16 6:58 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
725 | $0 | 13,113 (Direct) |
View |
| 2023-10-18 Exercise(A) |
2023-10-20 6:37 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
1,586 | $0 | 18,842 (Direct) |
View |
| 2023-10-05 Exercise |
2023-10-10 4:11 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
3,333 | $0 | 323,717 (Indirect) |
View |